The accelerating pace of U.S. FDA approvals for cell and gene therapies is “great for the field and great news for the patients,” but questions remain over commercialization, with “costs remaining ...

It’s a well-known and almost quaint fact that the human body is capable of regeneration. When we suffer a minor scrape or a ...

Regenerative medicine has become a major field of medical practice over the past few decades. But for most, these non-invasive and holistic treatments have remained inaccessible. Now, that’s starting ...

Global Scaffold Technology Market OverviewThe global scaffold technology market is experiencing substantial growth and is projected to expand at an impressive rate over the coming years. The ...

CANTON, Mass. (AP) — CANTON, Mass. (AP) — Organogenesis Holdings Inc. (ORGO) on Thursday reported a loss of $53.2 million in its first quarter. The Canton, Massachusetts-based company said it had a ...

NYBCe and CZ Biohub will derive iPSC lines from cord blood's immune cells, creating shared, broadly compatible resources for cell therapy, disease modelling, and AI-driven drug development.

Despite challenges for approval and access, regenerative therapies for retinal diseases may not be far away from becoming ...

Therapies like PRP and ACS have gained credibility when properly applied and studied, particularly in musculoskeletal conditions.

Forbes contributors publish independent expert analyses and insights. For decades, the ambitious goal of regenerative medicine has been to replace damaged or lost tissues with healthy, functioning ...

Ultrasome™ Demonstrates Strong Clinical Signal While Leveraging GMP-Produced CELZ-201 (Olastrocel) to Target Large, Underserved Osteoarthritis Market PHOENIX, April 28, 2026 (GLOBE NEWSWIRE) -- ...